Vitamin D and disease severity in bronchiectasis.
Aged
Biomarkers
/ blood
Bronchiectasis
/ diagnostic imaging
Disease Progression
Female
Humans
Inflammation
/ metabolism
Male
Middle Aged
Prevalence
Respiratory Function Tests
/ methods
Retrospective Studies
Severity of Illness Index
Tomography, X-Ray Computed
/ methods
Vitamin D
/ blood
Vitamin D Deficiency
/ complications
Biomarker
Bronchiectasis
Exacerbation
Severity
Vitamin D
Journal
Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
14
08
2018
revised:
08
01
2019
accepted:
20
01
2019
entrez:
5
3
2019
pubmed:
5
3
2019
medline:
24
3
2020
Statut:
ppublish
Résumé
Bronchiectasis is a complex respiratory disease characterised by permanent dilatation of bronchi. Vitamin D plays a role in infective disease by modulating the inflammation. Patients affected by bronchiectasis are frequently Vitamin D deficient and it correlates with lung function decline. We want to understand if there is a correlation between Vitamin D and clinical and radiological severity of bronchiectasis. We included 57 patients (17 males/40 female with mean age 60 ± 12 years) between October 2017 and March 2018. We excluded patients with cystic fibrosis, traction bronchiectasis and reporting Vitamin D supplementation. Bronchiectasis severity index (BSI) and Bhalla score were calculated, blood inflammatory markers and Vit. D were measured and lung function tests were performed. Vitamin D is deficient in 64% of patients, sufficient in 36% and normal in 7%. Mean BSI is 7.5 ± 5 and mean Bhalla score is 16 ± 4. Vitamin D levels correlate with Bhalla score (R We consider Vitamin D as a good predictor of clinical and radiological severity of bronchiectasis.
Sections du résumé
BACKGROUND
Bronchiectasis is a complex respiratory disease characterised by permanent dilatation of bronchi. Vitamin D plays a role in infective disease by modulating the inflammation. Patients affected by bronchiectasis are frequently Vitamin D deficient and it correlates with lung function decline. We want to understand if there is a correlation between Vitamin D and clinical and radiological severity of bronchiectasis.
METHODS
We included 57 patients (17 males/40 female with mean age 60 ± 12 years) between October 2017 and March 2018. We excluded patients with cystic fibrosis, traction bronchiectasis and reporting Vitamin D supplementation. Bronchiectasis severity index (BSI) and Bhalla score were calculated, blood inflammatory markers and Vit. D were measured and lung function tests were performed.
RESULTS
Vitamin D is deficient in 64% of patients, sufficient in 36% and normal in 7%. Mean BSI is 7.5 ± 5 and mean Bhalla score is 16 ± 4. Vitamin D levels correlate with Bhalla score (R
CONCLUSIONS
We consider Vitamin D as a good predictor of clinical and radiological severity of bronchiectasis.
Identifiants
pubmed: 30827468
pii: S0954-6111(19)30018-6
doi: 10.1016/j.rmed.2019.01.009
pii:
doi:
Substances chimiques
Biomarkers
0
Vitamin D
1406-16-2
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-5Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.